Abstract
A novel bacteriocin, plantaricin ZJ5 (PZJ5) was yielded from Lactobacillus plantarum ZJ5, cloned, and produced in Escherichia coli BL21 (DE3) pLys. The PZJ5 structural gene was fused with a Trx tag, and cloned into the pET32a plasmid under the control of the inducible lac operon. Induction was performed with isopropyl-β-D-thiogalactopyranoside (IPTG), with subsequent overexpression of the fusion protein, followed by purification to homogeneity via His affinity chromatography. Recombinant E. coli produced greater quantities of PZJ5 than L. plantarum ZJ5, and PZJ5 in E. coli was expressed in the form of soluble material. Biologically active PZJ5 was recovered by cleaving the purified fusion protein using enterokinase. The released PZJ5 demonstrated antibacterial activity against Micrococcus luteus. In this study, an inexpensive biological method using a Trx fusion system was presented, and for the first time, bacteriocin PZJ5 was expressed and purified in E. coli.
Author supplied keywords
Cite
CITATION STYLE
Song, D., Li, P., & Gu, Q. (2018). Cloning and heterologous expression of plantaricin ZJ5, a novel bacteriocin from lactobacillus plantarum ZJ5, in Escherichia coli. Natural Product Communications, 13(12), 1705–1708. https://doi.org/10.1177/1934578x1801301231
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.